Balyasny Asset Management LLC Kempharm, Inc Transaction History
Balyasny Asset Management LLC
- $72.4 Billion
- Q3 2025
A detailed history of Balyasny Asset Management LLC transactions in Kempharm, Inc stock. As of the latest transaction made, Balyasny Asset Management LLC holds 27,980 shares of KMPH stock, worth $138,221. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,980Holding current value
$138,221% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KMPH
# of Institutions
180Shares Held
37MCall Options Held
4.78MPut Options Held
1.25M-
Woodline Partners LP San Francisco, CA3.48MShares$17.2 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.08MShares$15.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.7MShares$13.3 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.23MShares$11 Million0.02% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.97MShares$9.74 Million0.39% of portfolio
About KEMPHARM, INC
- Ticker KMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,493,600
- Market Cap $170M
- Description
- KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...